FindTrial
Sign In

The comparison of the efficacy of intravenous ketorolac and ibuprofen in pain reduction in patients with acute low back pain presenting to the emergency department of Sina, Imam Khomeini and Shariati Hospitals in Tehran

The comparison of the efficacy of intravenous ketorolac and ibuprofen in pain reduction in patients with acute low back pain presenting to the emergency department of Sina, Imam Khomeini and Shariati Hospitals in Tehran

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151113025025N2
Enrollment
80
Registered
2018-09-30
Start date
2018-10-23
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute low back pain.

Interventions

Intervention 1: Intervention group: Intravenous Ibuprofen. Intervention 2: Intervention group: Intravenous Ketorolac.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who are over 18 years old. 2. Patients with low back pain due to musculoskeletal or isolated trauma to the back who present to the emergency department. 3. Patients who have completed ethical consent form to enter the study.

Exclusion criteria

Exclusion criteria: 1. Patients who have contraindications for Non-steroidal anti-inflammatory drug (NSAIDs) administration including peptic ulcer, gastrointestinal bleeding, uncontrolled hypertension, renal disease, inflammatory bowel disease, hypersensitivity or allergy to NSAIDs, asthma 2. Pregnancy 3. Patients suffering from multiple trauma.

Design outcomes

Primary

MeasureTime frame
Pain reduction. Timepoint: At the entrance to the emergency department, after 10, 30 and 60 minutes. Method of measurement: Pain intensity measured by Numeric rating scale.;Medication adverse effects. Timepoint: In the observation time. Method of measurement: Patient complaints of adverse effects during observation.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Bahreini

Tehran University of Medical Sciences

bahreinimaryam@gmail.com+98 21 6312 1413

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026